Cancer Weekly
Susan Hasty, Publisher
Table of Contents . . . February 6th, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Cancer Weekly | Other Publications
Blood Cancers - Stem Cell Transplant Patients Live Longer than Marrow Transplant Patients
Diagnostic Imaging - PET Detects Head and Neck Cancers
Anti-Angiogenesis - Growth Factor Antagonist NK4 Inhibits Tumor Growth and Metastasis
Cancer Vaccines - Protocol Elicits Anti-Carcinoembryonic Antigen Immune Responses
Cancer Vaccines - Recombinant Poxvirus Vaccines Initiate Strong Anti-Tumor Responses
Carcinogenesis - Transcription Factor May be Key to Hepatitis-Related Hepatocellular Carcinoma
Cutaneous T-Cell Lymphoma - Immunotherapy Targets Serologically Detect CTCL Antigens
Disease Markers - Plasma Factor More Prevalent in Younger Men with Prostate Cancer
Non-Hodgkin's Lymphoma - Patients with Stage III Follicular NHL May Benefit from Radiation Therapy
Tongue Carcinoma - Epithelial Adhesion Molecules: Underexpressed and Prognostic
Breast Cancer - Does Specialized Care Mean Better Care?
Cancer Genetics - Cancer-Linked BRCA2 Gene Plays Previously Unsuspected Role in Cell Division
Cancer Screening - Survey Suggests Many Physicians Don't Include Patients in Decisions
Epidemiology - MAGE-1 Gene Detected in Liver Cancers of Chinese Study Group
Glioma - Angiostatin K(1-3) Gene Transfer is Anti-Angiogenic
Hepatocellular Carcinoma - Doctors Should Consider Transplants for HCV-Related Cancer
Hepatocellular Carcinoma - Virology Makes Difference in Development of More Liver Tumors after Treatment
Leukemia - Cytogenetic Risk Factors Can Predict Therapy Outcome
Neuroblastoma - DNA Vaccine Effective in Murine Model
Neuroblastoma - Gene Therapy Approach Enhances Targeted Radiotherapy
Neuroblastoma - IL-2-Expressing Allogeneic Cell Vaccine Elicits Anti-Cancer Responses
Neuroblastoma - Retroviral Vector-Producer Cell Inhibits Angiogenesis
Non-Hodgkin's Lymphoma - Angiogenic Growth Factors Related to Poor Survival
Stem Cell Transplantation - Fludarine/Cyclophosphamide Immunosuppression Effective
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
